Obsidian Therapeutics

Obsidian Therapeutics is developing a new generation of controllable cell and gene therapies to safely and effectively treat serious diseases like cancer using its proprietary cytoDRiVE™ platform to precisely regulate protein levels and activity. 

Headquarters: Cambridge, MA
Website www.obsidiantx.com
Pipeline Preclinical
Twitter @Obsidian_tx
Partners Celgene